Accessibility Menu
Kenvue logo

Kenvue(NYSE) KVUE

Market Cap$36.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)-20%
5 YearN/A
1 Year-3%
1 Month-2%
Premium Feature
Moneyball Superscore
49/100
$18.70
-1.32%
-0.25Today
After hours$18.72+$0.01 (+0.08%)
Kenvue last closing stock price
MetricPriceDate
Last closeUSD 18.952026-09-03
Kenvue stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.3%USD 19.202026-08-27
1 month-1.99%USD 19.332026-08-04
3 month+8.19%USD 17.512026-06-05
Year to date+13.7%USD 16.672025-12-31
1 year-2.88%USD 19.512025-09-03
3 year-6.52%USD 20.272023-09-01
Since inception-19.53%USD 23.552023-05-04

Kenvue Financials at a Glance

Market Cap

$36.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$15.41B

Net Income (TTM)

$1.66B

EPS (TTM)

$0.86

P/E Ratio

21.97

Dividend

$0.83

Beta (Volatility)

0.00 (Low)

Price

$18.70

Volume

26,856,759

Open

$18.85

Previous Close

$18.74

Daily Range

$18.69 - $18.98

52-Week Range

$14.02 - $20.69

Estimated Earnings Date

Nov 2, 2026

KVUE: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kenvue

Kenvue Inc. makes health and wellness products for families worldwide. Its brands help people manage pain, allergies, and skin health. The company provides daily essentials like bandages and mouthwash.

Daily Essentials in Every Cabinet

  • Self Care: Products for coughs, pain relief, and smoking cessation; accounted for 40.2% of net sales in the fiscal three months ended June 28, 2026.
  • Skin Health and Beauty: Solutions for facial care, sun protection, and hair health; represented 28.1% of net sales in the fiscal three months ended June 28, 2026.
  • Essential Health: Everyday items for oral care, baby care, and wound treatment; made up 31.7% of net sales in the fiscal three months ended June 28, 2026.

New Paths and Big Partnerships

  • Approved a merger agreement in November 2025 where K-C will acquire all outstanding shares of the company.
  • Completed the transition to a fully independent public company in August 2023 following a separation from Johnson & Johnson.
  • Initiated the 2026 Restructuring Initiative in February 2026 to optimize the operating model and supply chain.
  • Launched new product innovations in Digestive Health and Wound Care across geographic markets in 2026.

Science and Scale

Kenvue uses digital marketing and research to develop products recommended by healthcare professionals. Its global distribution network allows it to sell brands in categories ranging from pain care to feminine wellness.

Looking at the Numbers

  • Net sales reached $3,955 million in the fiscal three months ended June 28, 2026, up 3.0% year over year.
  • Net income was $456 million in the fiscal three months ended June 28, 2026, up 8.6% year over year.
  • Cash and cash equivalents totaled $1,110 million as of June 28, 2026.
  • The company paid $796 million in dividends during the fiscal six months ended June 28, 2026.
  • Market capitalization was $37.8 billion according to recent company profile data.

Steady Growth Through Care

Kenvue has transitioned from a subsidiary into the world's largest pure-play consumer health company by revenue. Its focus on science-backed daily essentials and operational efficiency supports its evolution as an independent global leader.

AI Generated • Aug 6, 2026

Industry

Personal Products

Employees

22,000

CEO

Kirk L. Perry

Headquarters

Summit, NJ 07901, US

KVUE Financials

Key Financial Metrics (TTM)

Gross Margin

58.19%

Operating Margin

19.52%

Net Income Margin

10.76%

Return on Equity

15.58%

Return on Capital

14.02%

Return on Assets

6.20%

Earnings Yield

4.55%

Dividend Yield

4.39%

Payout Ratio

0.66%

Stock Overview

Market Cap

$36.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.92B

Volume

26.86M

Avg. Volume

20.39M

Financials (TTM)

Gross Profit

$8.97B

Operating Income

$3.01B

EBITDA

$3.17B

Operating Cash Flow

$2.33B

Capital Expenditure

-$208.20M

Free Cash Flow

$2.12B

Cash & ST Invst.

$1.11B

Total Debt

$8.48B

Kenvue Performance Analysis

Kenvue annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 14,929,000,000-0.8%
20232023-12-31USD 15,443,000,0003.4%
20242024-12-31USD 15,456,000,0000.1%
20252025-12-31USD 15,123,000,000-2.2%
Kenvue sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-28-2.0%
Q42025-12-280.4%
Q12026-03-293.4%
Q22026-06-281.2%
Kenvue annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.080.3%
20232023-12-31USD 0.87-19.4%
20242024-12-31USD 0.54-38.1%
20252025-12-31USD 0.7642.0%
Kenvue sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-28-4.5%
Q42025-12-28-19.0%
Q12026-03-2947.1%
Q22026-06-28-4.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.96B

+3.0%

Gross Profit

$2.30B

+1.8%

Gross Margin

58.18%

N/A

Market Cap

$36.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.66M

N/A

Employees

21,890

N/A

Net Income

$456.00M

+8.6%

EBITDA

$833.00M

-0.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.11B

+3.7%

Total Debt

$8.48B

-3.0%

Accounts Receivable

$2.93B

+2.5%

Inventory

$1.72B

-3.0%

Long Term Debt

$7.07B

-1.1%

Short Term Debt

$1.41B

-11.6%

Return on Assets

6.20%

N/A

Return on Invested Capital

14.41%

N/A

Free Cash Flow

$826.80M

+55.1%

Operating Cash Flow

$688.00M

+10.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ELThe Estée Lauder Companies Inc.
$103.86+2.97%
HSYThe Hershey Company
$173.15-1.09%
KMBKimberly-Clark Corporation
$104.96-2.77%
SYYSysco Corporation
$80.05-1.27%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About KVUE

What is the current price of Kenvue?

Kenvue is trading at $18.74 per share.

What is the 52-week range for Kenvue?

Over the past 52 weeks, Kenvue has traded between $14.02 and $20.69.

How much debt does Kenvue have?

As of the most recent reporting period, Kenvue reported total debt of $8.61B.

How much cash does Kenvue have on hand?

Kenvue reported $1.11B in cash and cash equivalents in its most recent financial results.

What is Kenvue’s dividend yield?

Kenvue currently has a dividend yield of 4.39%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.